{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:18:19Z","timestamp":1787667499294,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24fk0210113"],"award-info":[{"award-number":["JP24fk0210113"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP17K09435"],"award-info":[{"award-number":["JP17K09435"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20K08314"],"award-info":[{"award-number":["JP20K08314"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MEXTproject","award":["JPMXS0441500025"],"award-info":[{"award-number":["JPMXS0441500025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00535-026-02454-w","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T05:58:42Z","timestamp":1780293522000},"page":"1322-1333","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reelin level in serum-derived extracellular vesicles predicts regression of M2BPGi-defined liver fibrosis following hepatitis C virus eradication by direct-acting antiviral agents"],"prefix":"10.1007","volume":"61","author":[{"given":"Takanori","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Okina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Hojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Nagaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehisa","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"key":"2454_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00535-018-1503-x","volume":"54","author":"T Takehara","year":"2019","unstructured":"Takehara T, Sakamoto N, Nishiguchi S, et al. Efficacy and safety of sofosbuvir\u2013velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial. J Gastroenterol. 2019;54:87\u201395.","journal-title":"J Gastroenterol"},{"key":"2454_CR2","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00535-017-1427-x","volume":"53","author":"G Suda","year":"2018","unstructured":"Suda G, Ogawa K, Morikawa K, et al. Treatment of hepatitis C in special populations. J Gastroenterol. 2018;53:591\u2013605.","journal-title":"J Gastroenterol"},{"key":"2454_CR3","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.cmi.2016.09.017","volume":"22","author":"I Carmona","year":"2016","unstructured":"Carmona I, Cordero P, Ampuero J, et al. Role of assessing liver fibrosis in management of chronic hepatitis C virus infection. Clin Microbiol Infect. 2016;22:839\u201345.","journal-title":"Clin Microbiol Infect"},{"key":"2454_CR4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s00535-021-01845-5","volume":"57","author":"Y Tahata","year":"2022","unstructured":"Tahata Y, Hikita H, Mochida S, et al. Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosis. J Gastroenterol. 2022;57:120\u201332.","journal-title":"J Gastroenterol"},{"key":"2454_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-023-02039-x","author":"Y Tahata","year":"2023","unstructured":"Tahata Y, Hikita H, Mochida S, et al. Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus. J Gastroenterol. 2023. https:\/\/doi.org\/10.1007\/s00535-023-02039-x.","journal-title":"J Gastroenterol"},{"key":"2454_CR6","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1053\/j.gastro.2018.03.022","volume":"154","author":"O El-Sherif","year":"2018","unstructured":"El-Sherif O, Jiang ZG, Tapper EB, et al. Baseline factors associated with improvements in decompensated cirrhosis after direct-acting antiviral therapy for hepatitis C virus infection. Gastroenterology. 2018;154:2111-21.e8.","journal-title":"Gastroenterology"},{"key":"2454_CR7","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/hepr.13296","volume":"49","author":"Y Seko","year":"2019","unstructured":"Seko Y, Moriguchi M, Hara T, et al. Presence of varices in patients after hepatitis C virus eradication predicts deterioration in the FIB-4 index. Hepatol Res. 2019;49:473\u20138.","journal-title":"Hepatol Res"},{"key":"2454_CR8","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1002\/hep.29557","volume":"67","author":"E Mauro","year":"2018","unstructured":"Mauro E, Crespo G, Montironi C, et al. Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C. Hepatology. 2018;67:1683\u201394.","journal-title":"Hepatology"},{"key":"2454_CR9","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/srep01065","volume":"3","author":"A Kuno","year":"2013","unstructured":"Kuno A, Ikehara Y, Tanaka Y, et al. A serum \u201csweet-doughnut\u201d protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis. Sci Rep. 2013;3:1065.","journal-title":"Sci Rep"},{"key":"2454_CR10","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1111\/hepr.13823","volume":"52","author":"T Suzuki","year":"2022","unstructured":"Suzuki T, Matsuura K, Nagura Y, et al. Serum angiopoietin-2 levels predict regression of Mac-2 binding protein glycosylation isomer-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents. Hepatol Res. 2022;52:919\u201327.","journal-title":"Hepatol Res"},{"key":"2454_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/hepr.13962","volume":"54","author":"Y Nagura","year":"2024","unstructured":"Nagura Y, Suzuki T, Matsuura K, et al. Serum inducible protein 10 kDa\/C\u2013X\u2013C motif chemokine 10 levels predict regression of M2BPGi-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents. Hepatol Res. 2024;54:32\u201342.","journal-title":"Hepatol Res"},{"key":"2454_CR12","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00535-024-02115-w","volume":"59","author":"T Suzuki","year":"2024","unstructured":"Suzuki T, Matsuura K, Nagura Y, et al. MicroRNA-223-3p levels in serum-derived extracellular vesicles predict regression of M2BPGi-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents. J Gastroenterol. 2024;59:719\u201331.","journal-title":"J Gastroenterol"},{"key":"2454_CR13","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.1021\/pr0702060","volume":"6","author":"P Lescuyer","year":"2007","unstructured":"Lescuyer P, Hochstrasser D, Rabilloud T. How shall we use the proteomics toolbox for biomarker discovery? J Proteome Res. 2007;6:3371\u20136.","journal-title":"J Proteome Res"},{"key":"2454_CR14","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrd3978","volume":"12","author":"S Ela","year":"2013","unstructured":"Ela S, M\u00e4ger I, Breakefield XO, et al. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov. 2013;12:347\u201357.","journal-title":"Nat Rev Drug Discov"},{"key":"2454_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G van Niel","year":"2018","unstructured":"van Niel G, D\u2019Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19:213\u201328.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"19","key":"2454_CR16","doi-asserted-by":"publisher","first-page":"5992","DOI":"10.3390\/molecules26195992","volume":"26","author":"F Greco","year":"2021","unstructured":"Greco F, Anastasi F, Pardini LF, et al. Longitudinal bottom\u2013up proteomics of serum, serum extracellular vesicles, and cerebrospinal fluid reveals candidate biomarkers for early detection of glioblastoma in a murine model. Molecules. 2021;26(19):5992.","journal-title":"Molecules"},{"key":"2454_CR17","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/pmic.201000422","volume":"11","author":"F Raimondo","year":"2011","unstructured":"Raimondo F, Morosi L, Chinello C, et al. Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery. Proteomics. 2011;11:709\u201320.","journal-title":"Proteomics"},{"key":"2454_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129053","volume":"10","author":"R Sasaki","year":"2015","unstructured":"Sasaki R, Yamasaki K, Abiru S, et al. Serum wisteria floribunda agglutinin-positive Mac-2 binding protein values predict the development of hepatocellular carcinoma among patients with chronic hepatitis C after sustained virological response. PLoS ONE. 2015;10:e0129053.","journal-title":"PLoS ONE"},{"key":"2454_CR19","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/hep.27305","volume":"60","author":"K Yamasaki","year":"2014","unstructured":"Yamasaki K, Tateyama M, Abiru S, et al. Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients. Hepatology. 2014;60:1563\u201370.","journal-title":"Hepatology"},{"key":"2454_CR20","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/hep.27382","volume":"61","author":"G Xiao","year":"2015","unstructured":"Xiao G, Yang J, Yan L. Comparison of diagnostic accuracy of aspartate aminotransferase-to-platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis. Hepatology. 2015;61:292\u2013302.","journal-title":"Hepatology"},{"key":"2454_CR21","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","volume":"33","author":"PJ Johnson","year":"2015","unstructured":"Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach\u2014the ALBI grade. J Clin Oncol. 2015;33:550\u20138.","journal-title":"J Clin Oncol"},{"key":"2454_CR22","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1021\/acs.jproteome.2c00145","volume":"21","author":"AM Frankenfield","year":"2022","unstructured":"Frankenfield AM, Ni J, Ahmed M, et al. Protein contaminants matter: building universal protein contaminant libraries for DDA and DIA proteomics. J Proteome Res. 2022;21:2104\u201313.","journal-title":"J Proteome Res"},{"key":"2454_CR23","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1021\/pr4007602","volume":"13","author":"C Tu","year":"2014","unstructured":"Tu C, Mammen MJ, Li J, et al. Large-scale, ion-current-based proteomics investigation of bronchoalveolar lavage fluid in chronic obstructive pulmonary disease patients. J Proteome Res. 2014;13:627\u201339.","journal-title":"J Proteome Res"},{"key":"2454_CR24","first-page":"181","volume-title":"Primer of applied regression and analysis of variance","author":"S Glantz","year":"1990","unstructured":"Glantz S, Slinker B. Primer of applied regression and analysis of variance. McGraw-Hill; 1990. p. 181\u2013238."},{"key":"2454_CR25","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"2454_CR26","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1002\/hep.31639","volume":"72","author":"VW Setiawan","year":"2020","unstructured":"Setiawan VW, Rosen HR. Stratification of residual risk of HCC following HCV clearance with direct-acting antivirals in patients with advanced fibrosis and cirrhosis. Hepatology. 2020;72:1897\u20139.","journal-title":"Hepatology"},{"key":"2454_CR27","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1007\/s00535-014-1007-2","volume":"50","author":"M Abe","year":"2015","unstructured":"Abe M, Miyake T, Kuno A, et al. Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease. J Gastroenterol. 2015;50:776\u201384.","journal-title":"J Gastroenterol"},{"key":"2454_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/liv.13188","volume":"37","author":"X Zou","year":"2017","unstructured":"Zou X, Zhu MY, Yu DM, et al. Serum WFA(+) -M2BP levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection. Liver Int. 2017;37:35\u201344.","journal-title":"Liver Int"},{"key":"2454_CR29","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3233\/JAD-220322","volume":"90","author":"Y Huang","year":"2022","unstructured":"Huang Y, Driedonks TAP, Cheng L, et al. Brain tissue-derived extracellular vesicles in Alzheimer\u2019s disease display altered key protein levels including cell type-specific markers. J Alzheimers Dis. 2022;90:1057\u201372.","journal-title":"J Alzheimers Dis"},{"key":"2454_CR30","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1097\/QAD.0000000000003487","volume":"37","author":"Y Huang","year":"2023","unstructured":"Huang Y, Liao Z, Dang P, et al. Longitudinal characterization of circulating extracellular vesicles and small RNA during Simian immunodeficiency virus infection and antiretroviral therapy. AIDS. 2023;37:733\u201344.","journal-title":"AIDS"},{"key":"2454_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01741-x","volume":"22","author":"Y Lee","year":"2023","unstructured":"Lee Y, Ni J, Beretov J, et al. Recent advances of small extracellular vesicle biomarkers in breast cancer diagnosis and prognosis. Mol Cancer. 2023;22:33.","journal-title":"Mol Cancer"},{"key":"2454_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14356","volume":"24","author":"Y Huang","year":"2025","unstructured":"Huang Y, Feng J, Xu J, et al. Associations of age and sex with characteristics of extracellular vesicles and protein-enriched fractions of blood plasma. Aging Cell. 2025;24:e14356.","journal-title":"Aging Cell"},{"key":"2454_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.conb.2020.10.009","volume":"66","author":"G Faini","year":"2021","unstructured":"Faini G, Del Bene F, Albadri S. Reelin functions beyond neuronal migration: from synaptogenesis to network activity modulation. Curr Opin Neurobiol. 2021;66:135\u201343.","journal-title":"Curr Opin Neurobiol"},{"key":"2454_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/biom10060964","author":"Y Jossin","year":"2020","unstructured":"Jossin Y. Reelin functions, mechanisms of action and signaling pathways during brain development and maturation. Biomolecules. 2020. https:\/\/doi.org\/10.3390\/biom10060964.","journal-title":"Biomolecules"},{"key":"2454_CR35","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1073\/pnas.97.3.1281","volume":"97","author":"NR Smalheiser","year":"2000","unstructured":"Smalheiser NR, Costa E, Guidotti A, et al. Expression of Reelin in adult mammalian blood, liver, pituitary pars intermedia, and adrenal chromaffin cells. Proc Natl Acad Sci U S A. 2000;97:1281\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2454_CR36","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.advms.2021.01.006","volume":"66","author":"L Sturm","year":"2021","unstructured":"Sturm L, Roth L, Zoldan K, et al. Blood Reelin in the progression of chronic liver disease. Adv Med Sci. 2021;66:148\u201354.","journal-title":"Adv Med Sci"},{"key":"2454_CR37","first-page":"2745","volume":"61","author":"S Carotti","year":"2017","unstructured":"Carotti S, Perrone G, Amato M, et al. Reelin expression in human liver of patients with chronic hepatitis C infection. Eur J Histochem. 2017;61:2745.","journal-title":"Eur J Histochem"},{"key":"2454_CR38","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1515\/cclm-2014-0030","volume":"52","author":"SS Mansy","year":"2014","unstructured":"Mansy SS, Nosseir MM, Zoheiry MA, et al. Value of Reelin for assessing hepatic fibrogenesis in a group of Egyptian HCV-infected patients. Clin Chem Lab Med. 2014;52:1319\u201328.","journal-title":"Clin Chem Lab Med"},{"key":"2454_CR39","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.biocel.2007.10.021","volume":"40","author":"A Botella-Lopez","year":"2008","unstructured":"Botella-Lopez A, de Madaria E, Jover R, et al. Reelin is overexpressed in the liver and plasma of bile duct ligated rats and its levels and glycosylation are altered in plasma of humans with cirrhosis. Int J Biochem Cell Biol. 2008;40:766\u201375.","journal-title":"Int J Biochem Cell Biol"},{"key":"2454_CR40","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0168-8278(02)00050-8","volume":"36","author":"D Kobold","year":"2002","unstructured":"Kobold D, Grundmann A, Piscaglia F, et al. Expression of Reelin in hepatic stellate cells and during hepatic tissue repair: a novel marker for the differentiation of HSC from other liver myofibroblasts. J Hepatol. 2002;36:607\u201313.","journal-title":"J Hepatol"},{"key":"2454_CR41","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13500","volume":"56","author":"N Chen","year":"2023","unstructured":"Chen N, Liu S, Qin D, et al. Fate tracking reveals differences between Reelin(+) hepatic stellate cells (HSCs) and Desmin(+) HSCs in activation, migration and proliferation. Cell Prolif. 2023;56:e13500.","journal-title":"Cell Prolif"},{"key":"2454_CR42","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jhep.2024.10.044","volume":"82","author":"HY Kim","year":"2025","unstructured":"Kim HY, Rosenthal SB, Liu X, et al. Multi-modal analysis of human hepatic stellate cells identifies novel therapeutic targets for metabolic dysfunction-associated steatotic liver disease. J Hepatol. 2025;82:882\u201397.","journal-title":"J Hepatol"},{"key":"2454_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0271020","volume":"17","author":"K Shirai","year":"2022","unstructured":"Shirai K, Hikita H, Sakane S, et al. Serum amyloid P component and pro-platelet basic protein in extracellular vesicles or serum are novel markers of liver fibrosis in chronic hepatitis C patients. PLoS ONE. 2022;17:e0271020.","journal-title":"PLoS ONE"},{"key":"2454_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220663","volume":"14","author":"ML Yeh","year":"2019","unstructured":"Yeh ML, Huang CF, Huang CI, et al. Wisteria floribunda agglutinin-positive Mac-2-binding protein in the prediction of disease severity in chronic hepatitis B patients. PLoS ONE. 2019;14:e0220663.","journal-title":"PLoS ONE"},{"key":"2454_CR45","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1053\/j.gastro.2008.01.034","volume":"134","author":"M Friedrich-Rust","year":"2008","unstructured":"Friedrich-Rust M, Ong MF, Martens S, et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology. 2008;134:960\u201374.","journal-title":"Gastroenterology"},{"key":"2454_CR46","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1002\/hep.25936","volume":"56","author":"G Ferraioli","year":"2012","unstructured":"Ferraioli G, Tinelli C, Dal Bello B, et al. Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study. Hepatology. 2012;56:2125\u201333.","journal-title":"Hepatology"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-026-02454-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-026-02454-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-026-02454-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:18:29Z","timestamp":1787663909000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-026-02454-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2454"],"URL":"https:\/\/doi.org\/10.1007\/s00535-026-02454-w","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"3 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Yasuhito Tanaka: Research funding from AbbVie GK, AstraZeneca., FUJIREBIO Inc., Gilead Sciences, Inc., GlaxoSmithKline PLC., OTSUKA Pharmaceutical Co., Ltd., and Sysmex Corp. Lecture fees from AbbVie GK, ASKA Pharmaceutical Holdings Co., Ltd., AstraZeneca, Chugai Pharmaceutical Co., Ltd., Eisai, Gilead Sciences, Inc., GlaxoSmithKline PLC, and HU Frontier. Katsuya Nagaoka: Research funding from Eli Lilly Japan K.K. The authors (Kei Fujiwara, Hiromi Kataoka, Hayato Kawamura, Kentaro Matsuura, and Takanori Suzuki) declare that their department has received scholarship donations from OTSUKA Pharmaceutical Co., Ltd. However, these donations are not related to the subject of this study. The other authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}